Silencing EGFR/HER3 signaling with a novel anti-EGFR domain II/IV antibody
- Type
- Retraction
- Notice date
- 6/10/2017 0:00
- Journal
- Cancer Letters
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.canlet.2017.05.014
- Original paper DOI
- 10.1016/j.canlet.2014.11.053
Reasons
- Ethical Violations by Author
- False/Forged Authorship
- Compromised Peer Review
- Investigation by Journal/Publisher